The use of cyclosporine modifies the clinical and histopathological presentation of tuberculosis after renal transplantation
Open Access
- 1 August 2000
- journal article
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 42 (4) , 225-230
- https://doi.org/10.1590/s0036-46652000000400008
Abstract
Tuberculosis is one of the most frequent opportunistic infections after renal transplantation and occurred in 30 of 1264 patients transplanted between 1976 and 1996 at Hospital São Paulo - UNIFESP and Hospital Dom Silvério, Brazil. The incidence of 2.4% is five times higher than the Brazilian general population. The disease occurred between 50 days to 18 years after the transplant, and had an earlier and worse development in patients receiving azathioprine, prednisone and cyclosporine, with 35% presenting as a disseminated disease, while all patients receiving azathioprine and prednisone had exclusively pulmonary disease. Ninety percent of those patients had fever as the major initial clinical manifestation. Diagnosis was made by biopsy of the lesion (50%), positivity to M. tuberculosis in the sputum (30%) and spinal cerebral fluid analysis (7%). Duration of treatment ranged from 6 to 13 months and hepatotoxicity occurred in 3 patients. The patients who died had a significant greater number of rejection episodes and received higher doses of corticosteroid. In conclusion, the administration of cyclosporine changed the clinical and histopathological pattern of tuberculosis occurring after renal transplantation.Keywords
This publication has 29 references indexed in Scilit:
- Successful management of pulmonary tuberculosis in renal allograft recipients in a single centerKidney International, 1999
- Fatal primary multidrug-resistant tuberculosis in a heart transplant recipientTransplant International, 1998
- Sterile leukocyturia as a manifestation of urinary tuberculosis in renal transplant patients.Nephrology Dialysis Transplantation, 1998
- CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1Transplantation, 1997
- CYCLOSPORINE IMMUNOSUPPRESSION AND MYCOBACTERIAL INFECTIONSTransplantation, 1994
- Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme inductionClinical Pharmacology & Therapeutics, 1992
- Isoniazid Preventive Therapy for Tuberculosis: Decision Analysis Considering Ethnicity and GenderAmerican Review of Respiratory Disease, 1991
- TUBERCULOUS INTERSTITIAL NEPHRITIS AFTER KIDNEY TRANSPLANTATIONTransplantation, 1990
- Tuberculosis in patients with end-stage renal diseaseThe American Journal of Medicine, 1980
- Pulmonary Infection with M. kansasii in a Renal Transplant PatientNephron, 1980